Corneal Ulcer Treatment Market

2019 Analysis and Review of Corneal Ulcer Treatment Market by Drug Class - Antibiotics, Antifungals, Antivirals, Anti-amoebic Drugs, Corticosteroids, and NSAIDs for 2019-2029

  • 2020-02-03
  • REP-GB-6953
  • 63 Tables
  • 128 Figures
  • 244 pages
  • Format: PDF/PPT/Excel
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Corneal Ulcer Treatment Market to Reach US$ 1.3 Bn by 2029

Corneal ulcers is among the leading causes of blindness, particularly in developing regions, with factors such as improper usage of contact lenses and chemical exposure causing the disorder. As early diagnosis of corneal ulcers is an imperative to prevent partial or total blindness, the need for more effective treatment options is gaining ground. Moreover, various regulatory authorities - Food and Drug Administration (FDA) and European Medicines Agency (EMA) - are granting approvals to certain antibiotics, antifungal, and corticosteroids for eye infection treatment. Driven by such trends, the global corneal ulcer treatment market will register revenue worth US$ 1.3 Bn by 2029 end, following a promising growth curve.

Frequently Asked Questions about Corneal Ulcer Treatment Market

What is the global status of the corneal ulcer treatment market?

The global corneal ulcer treatment market is poised for a healthy CAGR over the period of forecast (2019-2029). Towards the end of 2025, the market for corneal ulcer treatment is most likely to surpass the billion-dollar market in revenue.

Will increase in the use of contact lenses affect the growth of the corneal ulcer treatment market?

It has been observed that people who use contact lenses are more susceptible to developing corneal ulcers as compared to the general population. Thus, increasing number of contact lens users due to reluctance of using eyeglasses is expected to result in increased number of corneal ulcers over the years, leading to healthy market growth during the forecast period.

How will new and alternate treatment options influence the corneal ulcer treatment market?

Treating corneal ulcers with conventional medications often leads to scaring of the cornea and blurred vision. This has prompted manufactures to develop novel and alternative medications such as dual therapies (drug combinations), which are expected to drive the growth of the corneal ulcer treatment market.

Who are the leading players in the corneal ulcer treatment market?

Some of the leading players in the corneal ulcer treatment market are:

  • Pfizer Inc.
  • Allergan plc
  • Novartis AG
  • Bayer AG

Why are corneal ulcer treatment market players focusing on North America and East Asia?

Owing to increasing per capita healthcare expenditure, favorable reimbursement policies, and strong presence of generic drug manufacturers, corneal ulcer treatment market players are eyeing North America and East Asia for increased revenue and bigger margins.

What is driving the corneal ulcer treatment market?

Rising prominence of corneal ulcers and increasing usage of contact lenses are currently driving the corneal ulcer treatment market. Increasing awareness regarding the prominence of corneal ulcers and emergence of novel treatment options are projected to boosting the popularity of corneal ulcer treatment in the near future.

Which distribution channel is expected to the most lucrative?

According to FMI, market players will continue to target retail pharmacies for lucrative returns during the forecast period of 2019-2029, followed by hospital pharmacies, online pharmacies, and drug stores.

Demand for Eye Drops/Ointments Remains Sustained Through 2029

Attributes such as cost-efficiency has led to a spurt in the adoption of eye drops/ointments, accounting for over 98% share the total demand. As eye drops/ointments eliminate the need for further interventional and oral route for drug dosage, they will continue to define stakeholders’ bottom lines throughout the forecast period. Further, by 2025, their sales will pass the billion-dollar mark. While they remain the preferred form of corneal ulcer treatment, tablets and pharmaceutical vials are likely to see sluggish demand growth through 2029.

North America Leads; Asian Markets to See Rising Adoption

Given the well-established supply chain of generic manufacturers as well as favorable reimbursement policies in developed regions, the corneal ulcer treatment market in North America continues to lead the pack in the global landscape. Being an early adopter of advanced healthcare, North America would remain the leader over the next decade. Although the market in Europe is also a significant revenue contributor, stakeholders are eyeing Asia for expanding their regional market presence. Primarily represented by China, and India, rising patient pool and increasing healthcare spending are key factors boosting market growth in these developing countries.

Exploring Novel Treatment Options for Better Disease Treatment

There are possibilities of patients complaining of scarring of the cornea and blurred vision despite early diagnosis and treatment of corneal ulcers, which, in turn, is compelling market players to explore novel treatment alternatives. In case of acanthamoeba keratitis, for instance, conventional antibiotics could be effective to some extent. As such, manufacturers are considering alternative approaches, including anti-amoebic drugs. Additionally, addressing corneal ulcers with dual therapy is also offering white spaces to players in the corneal ulcer treatment market.

Antibiotics capture higher demand share

Antifungals to see rapid traction

Eye drops/ointments account for 98% share

Steady demand for tablets

Retail pharmacies account for higher revenue share

Promising sales growth via hospital pharmacies

How Growth will Unfold

Adoption of various drug classes relies on the estimated caseloads of bacterial, viral, and fungal keratitis treatment, especially in developing regions. By capturing over 3/4 share of total demand, antibiotics will continue to be the preferable drug class for treating corneal ulcers during the period of projection. While antivirals are also witnessing a healthy adoption rate, increasing usage of antifungals are opening wide avenues of growth. Further, both medicinal drugs would account for a collective share of nearly 20% through 2029.

Corneal Ulcer Treatment Market Value by Drug Class 2019E

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Custom Market Research Services

FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Overview

Corneal Ulcer Treatment Market Analysis 2019-2029

A recent market study published by Future Market Insights on the corneal ulcer treatment market includes global industry analysis for 2014-2018 and opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the corneal ulcer treatment market, the growth prospects of the market are obtained with maximum precision.

Corneal Ulcer Treatment Market Taxonomy

The global corneal ulcer treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug Class

  • Antibiotics
  • Antifungals
  • Antivirals
  • Anti-amoebic Drugs
  • Corticosteroids
  • NSAIDs

Indication

  • Bacterial Keratitis
  • Fungal Keratitis
  • Viral Keratitis
  • Acanthamoeba Keratitis

Form

  • Tablets
  • Eye Drops / Ointments
  • Vials

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

What's Included

The report commences with the executive summary of the corneal ulcer treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the corneal ulcer treatment market.

Readers can find the detailed taxonomy and the definition of the corneal ulcer treatment market in this chapter, which will help them understand the basic information about the corneal ulcer treatment market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the corneal ulcer treatment market report.

The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.

This section includes the key inclusions of the report. It includes reimbursement scenario and epidemiology of spinal cord injuries, which could be necessary for the market expansion.

This section explain the global market value analysis and forecast for the corneal ulcer treatment market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the corneal ulcer treatment market along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019–2020), and an incremental opportunity for the forecast period (2019–2029).

This chapter explains the key macro-economic factors that are expected to influence the growth of the corneal ulcer treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the corneal ulcer treatment market. This chapter also highlights the key market dynamics of the corneal ulcer treatment market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the corneal ulcer treatment market.

Based on drug class, the corneal ulcer treatment market is segmented into antibiotics, antifungals, antivirals, anti-amoebic drugs, corticosteroids, and NSAID's. In this chapter, readers can find information about the key trends and developments in the corneal ulcer treatment market and market attractiveness analysis based on the drug class

Based on form, the corneal ulcer treatment market is segmented into tablets, eye drops, and vials. In this chapter, readers can find information about the key trends and developments in the corneal ulcer treatment market and market attractiveness analysis based on form.

Based on route of administration, the corneal ulcer treatment market is segmented into oral, topical and injectable. In this chapter, readers can find information about the key trends and developments in the corneal ulcer treatment market and market attractiveness analysis based on route of administration.

Based on indication, the corneal ulcer treatment market is segmented into bacterial keratitis, fungal keratitis, viral keratitis, and Acanthamoeba keratitis. In this chapter, readers can find information about the key trends and developments in the corneal ulcer treatment market and market attractiveness analysis based on the indication.

This chapter provides details about the corneal ulcer treatment market on the basis of distribution channel, and has been classified into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. In this chapter, readers can understand the market attractive analysis based on distribution channel.

This chapter explains how the corneal ulcer treatment market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

This chapter includes a detailed analysis of the growth of the North America corneal ulcer treatment market, along with a country-wise assessment that includes the U.S. and Canada.

Readers can find detailed information about several factors, such as the pricing analysis, which are impacting the growth of the Latin America corneal ulcer treatment market. This chapter also includes the growth prospects of the corneal ulcer treatment market in leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.

Important growth prospects of the corneal ulcer treatment market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia and the Rest of Europe, are included in this chapter.

India, Indonesia, Thailand, Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia corneal ulcer treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia corneal ulcer treatment market during the period 2019–2029.

This chapter highlights the growth of the corneal ulcer treatment market in East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the corneal ulcer treatment market in East Asia.

In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania corneal ulcer treatment market.

This chapter provides information about how the corneal ulcer treatment market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the Rest of MEA, during the forecast period 2019 - 2029.

In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in corneal ulcer treatment market along with their market presence analysis by region and product portfolio.

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the corneal ulcer treatment market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Pfizer Inc, Allergan plc, Novartis AG, Bayer AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Baxter International Inc., and Fresenius Kabi.

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the corneal ulcer treatment market report.

This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the corneal ulcer treatment market.

How the research was conducted?

Primary Research

  • C - Level Executives
  • Marketing Directors
  • Product Managers 
  • Business Development Officers 
  • Production Managers
  • Procurement Heads
  • Sales Executives
  • Distributors
  • Traders 
  • Raw Material Suppliers
  • Industry Experts
  • End Users
  • Current Market Dynamics and Challenges
  • Yesteryear Trends 
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

Secondary Research

  • Industry Publications
    • American Academy of Ophthalmology 
    • Medscape
    • Master Eye Associates
  • Industry Associations
    • International Atomic Energy Agency
    • International Council of Ophthalmology
  • Factiva
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Research Papers
  • Government Websites and Publications
  • Trade Websites

Primary Interview Splits

Primary Interview Splits corneal ulcer treatment market designation

Primary Interview Splits corneal ulcer treatment market stakeholder

To Learn More About our Comprehensive Perspective on Corneal Ulcer Treatment Market,

Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology